Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Isarna Therapeutics GmbH · 2003
ClinicalTrials.gov · Datasets · License: Public Domain · 2003
Open Source ↗
brain-tumorcancerglioblastomaimmunotherapytargeted-therapy
glioblastoma, anaplastic astrocytoma, antisense, cancer, transforming growth factor beta2 (tgf-beta2), targeted therapy, immunotherapy, brain tumor, central nervous system (cns), convection-enhanced delivery (ced) / microperfusion, locoregional application, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 848256
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.